https://news.osu.edu/lack-of-a-protein-in-lung-tumors-may-increase-risk-of-death/
Lack of A Protein In Lung Tumors May Increase Risk Of Death
[Embargoed until 8:00 P.M. ET Monday March 26, 2007, to coincide with online publication in the journal PLoS Medicine.] COLUMBUS , Ohio A study of human lung...
of alung tumorsmay increaselackprotein
https://biomesci.com/enterococcus-lung-tumors-mr1-mait-cells/
Enterococcus Activates MAIT Cells Against Lung Tumors
Sep 3, 2026 - Enterococcus bacteria activate MR1-restricted MAIT cells fighting lung cancer. Study on bacterial species and innate immune cell activation.
lung tumorsenterococcusactivatesmaitcells
https://avesis.ankara.edu.tr/yayin/7bc20479-b43b-4f03-9457-6ce2015ffcb4/bimanual-examination-is-indispensable-in-the-surgery-of-lung-metastatic-tumors
Bimanual Examination Is Indispensable in the Surgery of Lung Metastatic Tumors! | AVESİS
bimanual examinationthe surgerymetastatic tumorsindispensablelung
https://www.ashkarlab.com/post/new-publication-expanded-nk-cells-sensitize-lung-cancer-patients-tumors-to-pd1-blockade-therapy
New publication: Expanded NK cells sensitize lung cancer patients' tumors to PD1-blockade therapy!
Jan 27, 2021 - New study led by our rockstar PhD student, Sophie Poznanski, recently published in the Journal for ImmunoTherapy of Cancer shows that expanded NK cells from...
nk cellslung cancernewpublicationexpanded
https://profiles.foxchase.org/en/clippings/dxh9-depletion-may-expose-small-cell-lung-cancer-tumors-to-immune/
DXH9 Depletion May Expose Small Cell Lung Cancer Tumors to Immune System Attack - Fox Chase Cancer...
small celllung cancerimmune systemfox chasedepletion
https://www.carislifesciences.com/research/publications/further-molecular-profiling-of-tumors-harboring-therapeutic-targets-within-non-small-cell-lung-cancer/
Further molecular profiling of tumors harboring therapeutic targets within non-small cell lung...
Dec 29, 2021 - Background: Treatment of NSCLC has been revolutionized in recent years with the introduction of several targeted therapies for selected genetically altered...
molecular profilingsmall celltumorsharboringtherapeutic
https://www.oncnursingnews.com/view/selpercatinib-is-approved-for-2-ret-fusion-positive-solid-tumors-non-small-cell-lung-cancer
Selpercatinib Is Approved for RET Fusion–Positive Solid Tumors, Non–Small Cell Lung Cancer |...
Oct 9, 2026 - Selpercatinib was approved by the FDA for RET fusion–positive non–small cell lung cancer and locally advanced or metastatic RET fusion–positive solid tumors.
solid tumorslung cancerselpercatinibapprovedret